These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 2442262)
1. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells. Raychaudhuri S; Saeki Y; Chen JJ; Kohler H J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262 [TBL] [Abstract][Full Text] [Related]
2. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta). Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815 [TBL] [Abstract][Full Text] [Related]
3. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen. Raychaudhuri S; Saeki Y; Fuji H; Kohler H J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the idiotypic network in tumor immunity. Raychaudhuri S; Saeki Y; Chen JJ; Kohler H J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616 [TBL] [Abstract][Full Text] [Related]
5. Idiotypic intramolecular help. Induction of tumor-specific antibodies by monoclonal anti-idiotypic antibody with the help of Fc-specific T helper clones. Saeki Y; Chen JJ; Shi LF; Kohler H J Immunol; 1989 Apr; 142(8):2629-34. PubMed ID: 2522964 [TBL] [Abstract][Full Text] [Related]
6. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype. Shearer MH; Bright RK; Kennedy RC Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794 [TBL] [Abstract][Full Text] [Related]
7. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses. Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417 [TBL] [Abstract][Full Text] [Related]
8. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies. Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550 [TBL] [Abstract][Full Text] [Related]
9. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules. UytdeHaag F; Claassen I; Bunschoten H; Loggen H; Ottenhoff T; Teeuwsen V; Osterhaus A J Mol Cell Immunol; 1987; 3(3):145-55. PubMed ID: 2908179 [TBL] [Abstract][Full Text] [Related]
10. Characterization of "regulatory" idiotope-specific T cell clones to a monoclonal anti-idiotypic antibody mimicking a tumor-associated antigen (TAA). Saeki Y; Chen JJ; Shi LF; Raychaudhuri S; Köhler H J Immunol; 1989 Feb; 142(3):1046-52. PubMed ID: 2783599 [TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity. Ciavarra RP; Vitetta ES; Forman J J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help. Savelyeva N; King CA; Vitetta ES; Stevenson FK Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10987-92. PubMed ID: 16037207 [TBL] [Abstract][Full Text] [Related]
13. Idiotype-specific T helper clones recognize a variable H chain determinant. Saeki Y; Chen JJ; Shi LF; Okuda Y; Köhler H J Immunol; 1990 Mar; 144(5):1625-8. PubMed ID: 1689751 [TBL] [Abstract][Full Text] [Related]
14. Idiotype matching: correlation of expression of protective idiotype in sera with survival of tumor mice. Chen JJ; Saeki Y; Köhler H J Immunol; 1990 Jan; 144(2):759-64. PubMed ID: 2295810 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a hybridoma-derived T cell factor that promotes the production of antibodies bearing a dominant cross-reactive idiotype(s). Wardzala AM; Bowen MB; Jendrisak GS; Bellone CJ J Mol Cell Immunol; 1986; 2(5):243-53. PubMed ID: 2978231 [TBL] [Abstract][Full Text] [Related]
16. Sporadic idiotypic cross-reactivities between antibodies and T helper cells: one example of aleatory expression of T cell idiotypes. Martinez C; Coutinho A; Bandeira A; de la Hera A; Toribio M; Marcos MA; Pereira P J Mol Cell Immunol; 1987; 3(1):21-8. PubMed ID: 2978237 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of idiotype suppression. V. Anti-idiotype antibody inhibits early B cell triggering induced by antigen. Kim BS; Massey PB; Hui KM J Immunol; 1983 Feb; 130(2):596-601. PubMed ID: 6600243 [TBL] [Abstract][Full Text] [Related]
18. Recognition of idiotypes in lymphocyte interactions. I. Idiotypic selectivity in the cooperation between T and B lymphocytes. Hetzelberger D; Eichmann K Eur J Immunol; 1978 Dec; 8(12):846-52. PubMed ID: 83234 [TBL] [Abstract][Full Text] [Related]
19. Anti-idiotype antibodies: an alternative approach to tumor immunotherapy. Raychaudhuri S Indian J Exp Biol; 1989 Aug; 27(8):671-80. PubMed ID: 2699310 [TBL] [Abstract][Full Text] [Related]
20. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2. Raychaudhuri S; Kang CY; Kaveri SV; Kieber-Emmons T; Köhler H J Immunol; 1990 Jul; 145(2):760-7. PubMed ID: 2164069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]